Natural killer cells in severe asthma patients
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at immune cells called natural killer cells in people with severe asthma. Researchers want to see how these cells are different in people whose asthma is well-controlled, not well-controlled, or flaring up, compared to healthy volunteers without asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- A lung specialist has confirmed your severe asthma (either well-controlled, not well-controlled, or currently having a flare-up).
- You do not have other chronic inflammatory diseases besides asthma (for people with asthma).
- You have not used NSAID painkillers or opioids in the last 10 days.
- You are not pregnant, and you are not a current or former heavy smoker (more than 15 pack-years).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people with allergies or asthma compared to healthy people. It may help find new ways to treat these conditions.
This study looks at how certain immune cells (eosinophils) work in people with asthma. It compares people with mild to severe asthma, including those who have or haven't taken biologic treatments, against people without asthma. The goal is to better understand asthma and find new ways to treat it.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
This study looks at certain blood markers to see if they can help doctors measure how well your asthma is controlled. It might offer a new way to monitor your condition with a simple blood test.
This study aims to identify specific treatable traits in people with severe asthma and build a personalized treatment plan. It will help doctors understand which treatments might work best for you based on a detailed evaluation.
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
Hear when a new Asthma Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.